COVID-19 |

CCHS reviews patient-oriented research related to cardiac, vascular and hematological systems as well as related regulatory organ systems, including hemostasis. Applications reviewed in CCHS typically focus on studies which investigate cardiovascular physiology of humans, including studies related to autonomic regulation, exercise, and aging, as well as pathology associated with cardiovascular and hematological dysfunction, including thrombosis. Applications may include studies involving genetics, pharmacology, transfusion medicine, surgical procedures, toxicity, and environmental stressors. Proposed clinical trials which focus on mechanisms of health and/or disease may be reviewed in CCHS.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.

Topics


  • Human clinical studies, including pediatric populations, cardiovascular imaging, mechanisms and consequences of disease. Investigations may include physiology, pharmacology, electrophysiology, regional circulation, transfusion medicine, blood cell abnormalities, hemodynamics, cardiac mechanics, biomarker discovery, and genetic considerations in cardiovascular studies.
  • Disease states may include cardiac and vascular ischemia, heart failure/cardiomyopathy, metabolic syndrome, atherosclerosis, stroke, dyslipidemia, hypertension, obesity, diabetes, thyroid disease, general inflammation, hypercholesterolemia, and hematologic disorders such as sickle cell disease and hemophilia.
  • Modulation of cardiac/cardiovascular responses and adaptations including influence of sex, aging, pregnancy, and acute/chronic exercise on metabolic function and cardiac, vascular smooth muscle, and vascular endothelial function(s).
  • Neural control of the cardiovascular system including central and peripheral autonomic physiology, pharmacology, and receptor mechanisms in healthy and diseased populations.
  • Clinical studies investigating the responses of the cardiovascular system to trauma or surgery including arrhythmias associated with cardiac surgery or cardiopulmonary bypass, cardiac sudden death, resuscitation, stenting, pacemakers, cardiovascular injury and repair, and myocardial ischemia/reperfusion injury.
  • Environmental stresses, cardiovascular toxicity, and modifying conditions/stimuli including smoking, altitude, microgravity, heat, cold, bed rest/deconditioning, and environmental pollution in patients.

Shared Interests and Overlaps

CCHS and Epidemiology Study Sections – Panel A and Panel B (CHSA/B) have shared interests in topics of cardiovascular diseases in humans. Applications that emphasize epidemiology of cardiovascular disease in human populations will be reviewed in CHSA/B. Applications that emphasize clinical and mechanistic aspects of cardiovascular disease in humans will be reviewed in CCHS.

CCHS and Integrative Myocardial Physiology/Pathophysiology A (MPPA) have shared interests in heart failure and cardiomyopathy. Applications that emphasize basic and translational aspects of heart failure/cardiomyopathy, typically in animal models, will be reviewed in MPPA. Applications that emphasize clinical aspects of heart failure and cardiomyopathy in humans and human samples will be reviewed in CCHS.

CCHS and Integrative Vascular Physiology and Pathology (IVPP) have shared interests in topics related to blood pressure regulation, hypertension, neural control of the cardiovascular system, and micro- or regional circulation. Applications that emphasize the basic and translational aspects of these topic areas, typically in animal models, will be reviewed in IVPP. Applications that emphasize on clinical aspects of these topic areas in humans and human samples will be reviewed in CCHS.

CCHS and Atherosclerosis and Vascular Inflammation (AVI) have shared interests in topics related to atherosclerosis and inflammation of the vascular system. Applications that emphasize basic and translational aspects of these topic areas in cellular and animal models will be reviewed in AVI. Applications that emphasize clinical aspects of atherosclerosis and vascular inflammation in humans and human samples will be reviewed in CCHS.

CCHS and Human Studies of Diabetes and Obesity (HSDO) have shared interests in topics related to diabetes and obesity in humans. Applications that emphasize non-cardiovascular research applications related to diabetes and obesity will be reviewed in HSDO. Applications that emphasize on cardiovascular complications and endpoints related to diabetes and obesity will be reviewed in CCHS.

CCHS and Aging Systems and Geriatrics (ASG) have shared interests in aging related disorders which impact the cardiovascular system. Applications that emphasize patient-oriented applications involving modulation of cardiac and cardiovascular responses associated with aspects of aging or age-related diseases will be reviewed in ASG. Applications that emphasize clinical applications focused on evaluating cardiac and cardiovascular conditions and diseases in geriatric populations will be reviewed in CCHS.

CCHS and Therapeutic Development and Preclinical Studies (TDPS) have shared interests in human, patient-oriented studies. Applications that emphasize both animal models and human subjects, where the goal is largely pre-clinical, including resuscitation studies in animal models, will be reviewed in TDPS. Applications that emphasize studies in humans, in the context of clinical research/trials will be reviewed in CCHS.

CCHS and Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section (HTBT) have shared interests in transfusion medicine. All applications that emphasize non-clinical transfusion medicine studies will be reviewed in HTBT. Applications that emphasize clinical studies in transfusion medicine will be reviewed in CCHS.

CCHS and Surgery, Anesthesiology and Trauma Study Section (SAT) have shared interests in applications proposing investigations of ischemia reperfusion injury. Grant applications that focus on tissue, organ/multiorgan and systemic ischemia reperfusion injury, and that focus on host response including hormonal, metabolic, and immune response to ischemia reperfusion injury may be assigned to SAT. Applications that focus on patients oriented research on cardiovascular injury and repair, and myocardial ischemia/reperfusion injury may be assigned to CCHS.

There are shared interests between CCHS and Bioengineering, Technology and Surgical Sciences (BTSS) in the areas of the cardiovascular system. Applications which focus on clinical, population, or translational studies of the responses of the cardiovascular system to trauma or surgery: arrhythmias associated with cardiac surgery or cardiopulmonary bypass, cardiac sudden death, resuscitation, stenting, pacemakers; cardiovascular injury and repair, and myocardial ischemia/reperfusion injury are appropriate for CCHS. Applications which focus on aspects of cardiovascular surgery may be assigned to BTSS.